High levels of IL-6 and the soluble IL-6 receptor alpha chain (IL-6Rα) play an important role in suppression of the immune response in tumor progression of non-small cell lung cancer (NSCLC) (80). This evidence concerns the gene IL6 and non-small cell lung carcinoma.